Inovio Pharma (INO) Misses Q1 EPS by 4c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Epidemic response group to invest up to $384 mln in Novavax's COVID-19 vaccine
May 11, 2020 4:07 PM EDT(Reuters) - The Coalition for Epidemic Preparedness Innovations (CEPI) will invest up to $384 million to help develop and produce Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine candidate, the company said on Monday, sending its shares up 31.2% in extended trading.
CEPI, which was set up to fight emerging epidemics, said in March it would invest... More
Inovio Pharmaceuticals (INO) PT Raised to $9 at RBC Capital
May 7, 2020 6:14 AM EDTRBC Capital analyst Gregory Renza raised the price target on Inovio Pharmaceuticals (NASDAQ: INO) to $9.00 (from $7.00) while maintaining a Sector Perform rating.... More
